Holders over time
- ENSG
- ELV
| Quarter | ENSG | ELV |
|---|---|---|
| Q3 2020 | 2 holders, $3.8m | 30 holders, $15.0bn |
| Q4 2020 | 3 holders, $38m | 29 holders, $16.7bn |
| Q1 2021 | 1 holders, $31m | 25 holders, $18.6bn |
| Q2 2021 | none listed holders, n.a. | 30 holders, $19.4bn |
| Q3 2021 | 1 holders, $2.3m | 26 holders, $18.5bn |
| Q4 2021 | 1 holders, $4.8m | 29 holders, $23.3bn |
| Q1 2022 | 1 holders, $6.8m | 31 holders, $23.9bn |
| Q2 2022 | 3 holders, $12m | 32 holders, $23.3bn |
| Q3 2022 | 3 holders, $8.9m | 34 holders, $22.6bn |
| Q4 2022 | 3 holders, $55m | 34 holders, $25.5bn |
| Q1 2023 | 3 holders, $141m | 39 holders, $22.5bn |
| Q2 2023 | 4 holders, $182m | 38 holders, $20.6bn |
| Q3 2023 | 4 holders, $228m | 34 holders, $19.8bn |
| Q4 2023 | 3 holders, $301m | 36 holders, $20.3bn |
| Q1 2024 | 4 holders, $325m | 35 holders, $21.3bn |
| Q2 2024 | 4 holders, $320m | 33 holders, $22.1bn |
| Q3 2024 | 8 holders, $518m | 30 holders, $20.2bn |
| Q4 2024 | 7 holders, $470m | 32 holders, $15.9bn |
| Q1 2025 | 9 holders, $463m | 28 holders, $17.1bn |
| Q2 2025 | 7 holders, $696m | 27 holders, $14.8bn |
| Q3 2025 | 7 holders, $1.2bn | 27 holders, $12.7bn |
| Q4 2025 | 8 holders, $1.5bn | 25 holders, $17.0bn |
| Q1 2026 | 8 holders, $1.8bn | 26 holders, $13.6bn |
| Q2 2026 | 8 holders, $1.4bn | 28 holders, $17.7bn |
Ensign Group Inc
- Holders
- 8
- Reported value
- $518m
- Buyers
- 6
- Sellers
- 2
Breadth +4 among 94 comparable managers.
Elevance Health Inc Formerly
- Holders
- 30
- Reported value
- $20.2bn
- Buyers
- 16
- Sellers
- 16
Breadth 0 among 94 comparable managers.
Who holds both, Q3 2024
Both (4)
Baillie Gifford & Co, Brevan Howard Capital Management LP, ExodusPoint Capital Management LP, First Eagle Investment Management LLC
Only ENSG (4)
Capital Research Global Investors, Caxton Associates LLP, Quantbot Technologies LP, Winton Group Ltd
Only ELV (26)
AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Artisan Partners LP, Balyasny Asset Management LLC, Bridgewater Associates LP, Dodge & Cox, Eisler Capital Management Ltd, Fidelity (FMR LLC), Holocene Advisors LP, Invesco Ltd, Janus Henderson Group Ltd, Man Group PLC, MFS Investment Management, Millennium Management LLC, Moore Capital Management LP, Neuberger Berman Group LLC, Ruane Cunniff & Goldfarb LP, Schonfeld Strategic Advisors LLC, Squarepoint Ops LLC, T. Rowe Price Associates Inc, Tudor Investment Corp, Two Sigma Investments LP, Verition Fund Management LLC, Voloridge Investment Management LLC, and 1 more
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.